{
    "id": 9810,
    "fullName": "CXCR4 S344fs",
    "impact": "frameshift",
    "proteinEffect": "gain of function",
    "geneVariantDescriptions": [
        {
            "description": "CXCR4 S344fs results in a change in the amino acid sequence of the Cxcr4 protein beginning at aa 344 of 352, likely resulting in premature truncation of the functional protein (UniProt.org). S344fs results in decreased internalization of Cxcr4 and increased activation of AKT1 and MAPK1 in the presence of Cxcl12 in cell culture (PMID: 25371371).",
            "references": [
                {
                    "id": 3354,
                    "pubMedId": 25371371,
                    "title": "CXCR4 WHIM-like frameshift and nonsense mutations promote ibrutinib resistance but do not supplant MYD88(L265P) -directed survival signalling in Waldenstr\u00f6m macroglobulinaemia cells.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/25371371"
                },
                {
                    "id": 295,
                    "pubMedId": null,
                    "title": null,
                    "url": "https://www.uniprot.org"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 7852,
        "geneSymbol": "CXCR4",
        "terms": [
            "CXCR4",
            "CD184",
            "D2S201E",
            "FB22",
            "HM89",
            "HSY3RR",
            "LAP-3",
            "LAP3",
            "LCR1",
            "LESTR",
            "NPY3R",
            "NPYR",
            "NPYRL",
            "NPYY3R",
            "WHIM",
            "WHIMS"
        ]
    },
    "variant": "S344fs",
    "createDate": "07/29/2015",
    "updateDate": "07/29/2015",
    "referenceTranscriptCoordinates": {
        "id": 170944,
        "transcript": "NM_003467",
        "gDna": "chr2:g.(136114898_136114899)",
        "cDna": "c.(1030_1029)",
        "protein": "p.S344fs",
        "sourceDb": "RefSeq",
        "refGenomeBuild": "GRCh38/hg38"
    },
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 2627,
            "approvalStatus": "Preclinical",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, co-treatment with Mozobil (plerixafor) overcame resistance to Imbruvica (Ibrutinib) in Waldenstrom macroglobulinemia cells harboring MYD88 L265P and expressing CXCR4 S344fs in the presence of CXCL12 in culture (PMID: 25371371).",
            "molecularProfile": {
                "id": 9807,
                "profileName": "CXCR4 S344fs MYD88 L265P"
            },
            "therapy": {
                "id": 2969,
                "therapyName": "Ibrutinib + Plerixafor",
                "synonyms": null
            },
            "indication": {
                "id": 50747,
                "name": "lymphoplasmacytic lymphoma",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 3354,
                    "pubMedId": 25371371,
                    "title": "CXCR4 WHIM-like frameshift and nonsense mutations promote ibrutinib resistance but do not supplant MYD88(L265P) -directed survival signalling in Waldenstr\u00f6m macroglobulinaemia cells.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/25371371"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 2624,
            "approvalStatus": "Preclinical",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, Waldenstrom macroglobulinemia cells harboring MYD88 L265P and expressing CXCR4 S344fs demonstrated resistance to Imbruvica (Ibrutinib) in the presence of CXCL12 in culture (PMID: 25371371).",
            "molecularProfile": {
                "id": 9807,
                "profileName": "CXCR4 S344fs MYD88 L265P"
            },
            "therapy": {
                "id": 768,
                "therapyName": "Ibrutinib",
                "synonyms": null
            },
            "indication": {
                "id": 50747,
                "name": "lymphoplasmacytic lymphoma",
                "source": "DOID"
            },
            "responseType": "resistant",
            "references": [
                {
                    "id": 3354,
                    "pubMedId": 25371371,
                    "title": "CXCR4 WHIM-like frameshift and nonsense mutations promote ibrutinib resistance but do not supplant MYD88(L265P) -directed survival signalling in Waldenstr\u00f6m macroglobulinaemia cells.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/25371371"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 2630,
            "approvalStatus": "Preclinical",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, treatment with IMG-2005-5 induced apoptosis in Waldenstrom macroglobulinemia cells harboring MYD88 L265P and expressing CXCR4 S344fs in culture (PMID: 25371371).",
            "molecularProfile": {
                "id": 9807,
                "profileName": "CXCR4 S344fs MYD88 L265P"
            },
            "therapy": {
                "id": 2868,
                "therapyName": "IMG-2005-5",
                "synonyms": null
            },
            "indication": {
                "id": 50747,
                "name": "lymphoplasmacytic lymphoma",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 3354,
                    "pubMedId": 25371371,
                    "title": "CXCR4 WHIM-like frameshift and nonsense mutations promote ibrutinib resistance but do not supplant MYD88(L265P) -directed survival signalling in Waldenstr\u00f6m macroglobulinaemia cells.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/25371371"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 9800,
            "profileName": "CXCR4 S344fs",
            "profileTreatmentApproaches": [
                {
                    "id": 6328,
                    "name": "CXCR4 Inhibitor",
                    "profileName": "CXCR4 S344fs"
                }
            ]
        },
        {
            "id": 9807,
            "profileName": "CXCR4 S344fs MYD88 L265P",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        {
            "id": 170944,
            "transcript": "NM_003467",
            "gDna": "chr2:g.(136114898_136114899)",
            "cDna": "c.(1030_1029)",
            "protein": "p.S344fs",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        }
    ]
}